Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McIntyre, Roger S
Muzina, David J
Adams, Amanda
Lourenco, Maria Teresa C
Law, Candy WY
Soczynska, Joanna K
Woldeyohannes, Hanna O
Nathanson, Jay
and
Kennedy, Sidney H
2009.
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
Expert Opinion on Pharmacotherapy,
Vol. 10,
Issue. 18,
p.
3061.
Komossa, Katja
Depping, Anna M
Gaudchau, Andrea
Kissling, Werner
and
Leucht, Stefan
2010.
Second-generation antipsychotics for major depressive disorder and dysthymia.
Cochrane Database of Systematic Reviews,
Nakajima, Shinichiro
Suzuki, Takefumi
Watanabe, Koichiro
Kashima, Haruo
and
Uchida, Hiroyuki
2010.
Potential risks of adjunctive use of atypical antipsychotic drugs for the treatment of depression.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 2,
p.
435.
Pae, Chi-Un
Sohi, Manmohandeep Singh
Seo, Ho-Jun
Serretti, Alessandro
Patkar, Ashwin A.
Steffens, David C.
and
Masand, Prakash S.
2010.
Quetiapine XR: Current status for the treatment of major depressive disorder.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 7,
p.
1165.
Salerian, Alen J.
2010.
Thermodynamic laws apply to brain function.
Medical Hypotheses,
Vol. 74,
Issue. 2,
p.
270.
Liebowitz, Michael
Lam, Raymond W.
Lepola, Ulla
Datto, Catherine
Sweitzer, Dennis
and
Eriksson, Hans
2010.
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial.
Depression and Anxiety,
Vol. 27,
Issue. 10,
p.
964.
Cristancho, Mario A.
and
Thase, Michael E.
2010.
The role of quetiapine extended release in the treatment of bipolar depression.
Advances in Therapy,
Vol. 27,
Issue. 11,
p.
774.
Bandelow, Borwin
Chouinard, Guy
Bobes, Julio
Ahokas, Antti
Eggens, Ivan
Liu, Sherry
and
Eriksson, Hans
2010.
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
The International Journal of Neuropsychopharmacology,
Vol. 13,
Issue. 03,
p.
305.
Steinert, Tilman
and
Jandl, Martin
2010.
Are antipsychotics antipsychotics?.
Psychopharmacology,
Vol. 212,
Issue. 1,
p.
117.
Pae, Chi-Un
2010.
Accelerating response to antidepressant treatment in depression: A possible role for atypical antipsychotics.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 34,
Issue. 2,
p.
434.
El-Khalili, Nizar
Joyce, Mark
Atkinson, Sarah
Buynak, Robert J.
Datto, Catherine
Lindgren, Petter
and
Eriksson, Hans
2010.
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
The International Journal of Neuropsychopharmacology,
Vol. 13,
Issue. 07,
p.
917.
2010.
The Use and Misuse of Psychiatric Drugs.
p.
165.
Ravindran, Arun V
Al-Subaie, Abdullah
and
Abraham, Gebrehiwot
2010.
Quetiapine: novel uses in the treatment of depressive and anxiety disorders.
Expert Opinion on Investigational Drugs,
Vol. 19,
Issue. 10,
p.
1187.
Bauer, Michael
El-Khalili, Nizar
Datto, Catherine
Szamosi, Johan
and
Eriksson, Hans
2010.
A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
Journal of Affective Disorders,
Vol. 127,
Issue. 1-3,
p.
19.
Wang, Zuowei
Kemp, David E.
Chan, Philip K.
Fang, Yiru
Ganocy, Stephen J.
Calabrese, Joseph R.
and
Gao, Keming
2011.
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorder.
The International Journal of Neuropsychopharmacology,
Vol. 14,
Issue. 01,
p.
131.
Chen, Jun
Gao, Keming
and
Kemp, David E
2011.
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Current Opinion in Psychiatry,
Vol. 24,
Issue. 1,
p.
10.
Schwartz, Thomas L.
Siddiqui, Umar A.
and
Stahl, Stephen M.
2011.
Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor.
Therapeutic Advances in Psychopharmacology,
Vol. 1,
Issue. 3,
p.
81.
Wu, Renrong
Kemp, David E.
Sajatovic, Martha
Zhao, Jingping
Calabrese, Joseph R.
and
Gao, Keming
2011.
Communication of Potential Benefits and Harm to Patients and Payers in Psychiatry: A Review and Commentary.
Clinical Therapeutics,
Vol. 33,
Issue. 12,
p.
B62.
Schwartz, Thomas L.
and
Stahl, Stephen M.
2011.
Treatment Strategies for Dosing the Second Generation Antipsychotics.
CNS Neuroscience & Therapeutics,
Vol. 17,
Issue. 2,
p.
110.
Stein, Dan J.
Bandelow, Borwin
Merideth, Charles
Olausson, Bengt
Szamosi, Johan
and
Eriksson, Hans
2011.
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8‐week placebo‐controlled studies.
Human Psychopharmacology: Clinical and Experimental,
Vol. 26,
Issue. 8,
p.
614.